| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), CRNX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 147.7K | - | - | |
| COO | 121.9K | - | - | |
| CEO | 111.1K | - | - | |
| CFO | 84.8K | - | - | |
| Other | 66.8K | $1.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Kalofonos Isabel | Chief Commercial Officer | Sale+OE10b5-1 | 2,500 | $55.00 | $137,500.00 | -75.0% | -21.8% | - | |
| Dec 1, 2025 | Pizzuti Dana56 | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $45.02 | $225,100.00 | -7.0% | -10.0% | - | |
| Nov 3, 2025 | Pizzuti Dana56 | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $42.66 | $213,312.00 | -7.0% | +15.2% | - | |
| Oct 1, 2025 | Pizzuti Dana56 | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $41.81 | $209,050.00 | -7.0% | +13.9% | - | |
| Sep 26, 2025 | Struthers Richard Scott54 | President &CEO | Sell10b5-1 | 4,000 | $45.00 | $180,000.00 | -3.6% | +4.5% | - | |
| Sep 26, 2025 | Fust Matthew K77 | Director | Sale+OE10b5-1 | 16,000 | $44.75 | $716,000.00 | -41.2% | +4.5% | - | |
| Sep 2, 2025 | Pizzuti Dana56 | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $32.10 | $160,500.00 | -4.9% | +35.9% | +155.1% | |
| Aug 22, 2025 | Pizzuti Dana56 | Chief Med and Dev Officer | Sale+OE10b5-1 | 30,000 | $30.43 | $912,900.00 | -31.2% | +35.7% | +173.9% | |
| Aug 20, 2025 | Pizzuti Dana56 | Chief Med and Dev Officer | Sell10b5-1 | 6,492 | $29.18 | $189,436.56 | -8.9% | +47.9% | +191.1% | |
| Jun 12, 2025 | Betz Stephen F.61 | Chief Scientific Officer | Sale+OE10b5-1 | 97,483 | $32.23 | $3,141,877.09 | -49.4% | +8.8% | +7.1% |